4.5 Article

Neurovascular In-Stent Stenoses: Treatment with Conventional and Drug-Eluting Balloons

Related references

Note: Only part of the references are listed.
Article Cardiac & Cardiovascular Systems

Pharos Neurovascular Intracranial Stent: Elective Use for a Symptomatic Stenosis Refractory to Medical Therapy

J. Mocco et al.

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2009)

Article Cardiac & Cardiovascular Systems

Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter

Bruno Scheller et al.

CLINICAL RESEARCH IN CARDIOLOGY (2008)

Article Medicine, General & Internal

Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg

Gunnar Tepe et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Article Clinical Neurology

Influence of patient age and stenosis location on Wingspan in-stent restenosis

A. S. Turk et al.

AMERICAN JOURNAL OF NEURORADIOLOGY (2008)

Article Cardiac & Cardiovascular Systems

Pactitaxel treatment reduces neointimal hyperplasia in cultured human saphenous veins

Thomas Schachner et al.

EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2007)

Review Cardiac & Cardiovascular Systems

Drug-eluting stent update 2007 - Part II: Unsettled issues

Joost Daemen et al.

CIRCULATION (2007)

Article Clinical Neurology

Angioplasty for symptomatic intracranial stenosis - Clinical outcome

MP Marks et al.

STROKE (2006)

Article Medicine, General & Internal

Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis

MI Chimowitz et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Article Cardiac & Cardiovascular Systems

Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis

B Scheller et al.

CIRCULATION (2004)